These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 16624467

  • 1. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.
    Yoon SJ, Pae CU, Kim DJ, Namkoong K, Lee E, Oh DY, Lee YS, Shin DH, Jeong YC, Kim JH, Choi SB, Hwang IB, Shin YC, Cho SN, Lee HK, Lee CT.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1196-201. PubMed ID: 16624467
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
    Altintoprak AE, Zorlu N, Coskunol H, Akdeniz F, Kitapcioglu G.
    Hum Psychopharmacol; 2008 Jun 30; 23(4):313-9. PubMed ID: 18327889
    [Abstract] [Full Text] [Related]

  • 3. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group.
    Curr Med Res Opin; 2003 Jun 30; 19(8):737-46. PubMed ID: 14687445
    [Abstract] [Full Text] [Related]

  • 4. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
    Saiz-Ruiz J, Montes JM, Ibáñez A, Díaz M, Vicente F, Pelegrín C, Viñas R, Arias F, Carrasco JL, Ferrando L.
    Hum Psychopharmacol; 2005 Aug 30; 20(6):435-40. PubMed ID: 16106478
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE, Yoon SJ, Kim J, Jung JY, Jeong HS, Cho HB, Shin E, Lyoo IK, Kim TS.
    Int J Clin Pract; 2011 Mar 30; 65(3):323-9. PubMed ID: 21314870
    [Abstract] [Full Text] [Related]

  • 6. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
    Martinotti G, Andreoli S, Di Nicola M, Di Giannantonio M, Sarchiapone M, Janiri L.
    Hum Psychopharmacol; 2008 Jul 30; 23(5):417-24. PubMed ID: 18425995
    [Abstract] [Full Text] [Related]

  • 7. [A double-blind controlled study of the efficacy and acceptability of tianeptine in comparison with fluvoxamine in the treatment of depressed alcoholic patients].
    Habrat B, Załoga B.
    Psychiatr Pol; 2006 Jul 30; 40(3):579-97. PubMed ID: 17037821
    [Abstract] [Full Text] [Related]

  • 8. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
    Liappas J, Paparrigopoulos T, Tzavellas E, Rabavilas A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan 30; 29(1):55-60. PubMed ID: 15610945
    [Abstract] [Full Text] [Related]

  • 9. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr 30; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 10. Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older.
    Nelson JC, Hollander SB, Betzel J, Smolen P, Mirtazapine Nursing Home Study Group.
    Int J Geriatr Psychiatry; 2006 Sep 30; 21(9):898-901. PubMed ID: 16955423
    [Abstract] [Full Text] [Related]

  • 11. The effect of mirtazapine in patients with chronic pain and concomitant depression.
    Freynhagen R, Muth-Selbach U, Lipfert P, Stevens MF, Zacharowski K, Tölle TR, von Giesen HJ.
    Curr Med Res Opin; 2006 Feb 30; 22(2):257-64. PubMed ID: 16466597
    [Abstract] [Full Text] [Related]

  • 12. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
    Varia I, Venkataraman S, Hellegers C, Gersing K, Doraiswamy PM.
    Psychopharmacol Bull; 2007 Feb 30; 40(1):47-56. PubMed ID: 17285095
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
    Kim SW, Shin IS, Kim JM, Kim YC, Kim KS, Kim KM, Yang SJ, Yoon JS.
    Psychiatry Clin Neurosci; 2008 Feb 30; 62(1):75-83. PubMed ID: 18289144
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.
    Int Clin Psychopharmacol; 2003 May 30; 18(3):133-41. PubMed ID: 12702891
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy, tolerability and safety of tianeptine in special populations of depressive patients.
    Vuković O, Marić NP, Britvić D, Cvetić T, Damjanović A, Prostran M, Jasović-Gasić M.
    Psychiatr Danub; 2009 Jun 30; 21(2):194-8. PubMed ID: 19556948
    [Abstract] [Full Text] [Related]

  • 17. Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study.
    Gambi F, De Berardis D, Campanella D, Carano A, Sepede G, Salini G, Mezzano D, Cicconetti A, Penna L, Salerno RM, Ferro FM.
    J Psychopharmacol; 2005 Sep 30; 19(5):483-7. PubMed ID: 16166185
    [Abstract] [Full Text] [Related]

  • 18. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 Sep 30; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 19. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J, Prochazka J, Odén A, Sjödin I, Dahl ML, Ahlner J, Bengtsson F.
    Hum Psychopharmacol; 2006 Apr 30; 21(3):151-8. PubMed ID: 16444795
    [Abstract] [Full Text] [Related]

  • 20. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
    Pasquini M, Biondi M, Costantini A, Cairoli F, Ferrarese G, Picardi A, Sternberg C.
    Depress Anxiety; 2006 Apr 30; 23(7):441-8. PubMed ID: 16841345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.